Unique Genomic Profile of Fibrolamellar Hepatocellular Carcinoma
Open Access
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 148 (4) , 806-818.e10
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic (P30DK084567, R01CA165076)
- Samuel Waxman Cancer Research Foundation
- Fundación Cellex
- Seventh Framework Programme (259744)
- National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK076986, R01 DK099558)
- Instituto de Salud Carlos III (ISCIII/FIS FI10/00143)
- Associazione Italiana per la Ricerca sul Cancro (5x1000)
- National Institutes of Health (P01/DK072201)
- Institut National Du Cancer
- National Cancer Institute
- Generalitat de Catalunya
- Ministerio de Educación, Cultura y Deporte (FPU12/05138)
This publication has 61 references indexed in Scilit:
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Understanding resistance to EGFR inhibitors—impact on future treatment strategiesNature Reviews Clinical Oncology, 2010
- Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent AdvancementsSeminars in Liver Disease, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancerHepatology, 2008
- GenePattern 2.0Nature Genetics, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005